ARMC
BMY.RT

American Research & Management Company’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

American Research & Management Company’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,915
Closed -$11K – 398
2020
Q4 		$11K Hold
15,915
– – ﹤0.01% 290
2020
Q3 		$36K Hold
15,915
– – 0.01% 201
2020
Q2 		$57K Hold
15,915
– – 0.02% 179
2020
Q1 		$60K Hold
15,915
– – 0.02% 165
2019
Q4 		$48K Buy
+15,915
New +$41.4K 0.01% 190

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

American Research & Management Company's BMY.RT Position: Q1 2021 in Review

American Research & Management Company sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 15,915 shares — an estimated $11K sold.

American Research & Management Company first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $60K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • American Research & Management Company reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • American Research & Management Company sold 15,915 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $11K.
  • American Research & Management Company first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • American Research & Management Company's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $60K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on American Research & Management Company's 13F filing for Q1 2021, filed 6 Apr 2021.